PL2326307T3 - Sposób wytwarzania krystalicznych mikrocząstek substancji czynnej - Google Patents

Sposób wytwarzania krystalicznych mikrocząstek substancji czynnej

Info

Publication number
PL2326307T3
PL2326307T3 PL09776893T PL09776893T PL2326307T3 PL 2326307 T3 PL2326307 T3 PL 2326307T3 PL 09776893 T PL09776893 T PL 09776893T PL 09776893 T PL09776893 T PL 09776893T PL 2326307 T3 PL2326307 T3 PL 2326307T3
Authority
PL
Poland
Prior art keywords
active ingredient
producing crystalline
crystalline active
ingredient microparticles
microparticles
Prior art date
Application number
PL09776893T
Other languages
English (en)
Inventor
Detlef Grawe
Sabine Gliesing
Robert Eilers
Original Assignee
Jesalis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41138903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2326307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jesalis Pharma Gmbh filed Critical Jesalis Pharma Gmbh
Publication of PL2326307T3 publication Critical patent/PL2326307T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04R—LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; ELECTRIC HEARING AIDS; PUBLIC ADDRESS SYSTEMS
    • H04R5/00—Stereophonic arrangements

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Signal Processing (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PL09776893T 2008-08-08 2009-06-30 Sposób wytwarzania krystalicznych mikrocząstek substancji czynnej PL2326307T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008037025.8A DE102008037025C5 (de) 2008-08-08 2008-08-08 Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
EP09776893.1A EP2326307B1 (de) 2008-08-08 2009-06-30 Verfahren zur herstellung kristalliner wirkstoff-mikropartikel
PCT/EP2009/004724 WO2010015298A2 (de) 2008-08-08 2009-06-30 Kristalline wirkstoff-mikropartikel, verfahren zu deren herstellung und verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
PL2326307T3 true PL2326307T3 (pl) 2016-04-29

Family

ID=41138903

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09776893T PL2326307T3 (pl) 2008-08-08 2009-06-30 Sposób wytwarzania krystalicznych mikrocząstek substancji czynnej

Country Status (14)

Country Link
US (1) US9173843B2 (pl)
EP (2) EP2326307B1 (pl)
CN (1) CN102112113B (pl)
AU (1) AU2009278348B2 (pl)
CA (1) CA2732952C (pl)
CH (1) CH701977B1 (pl)
DE (1) DE102008037025C5 (pl)
DK (1) DK2326307T3 (pl)
ES (1) ES2557904T3 (pl)
HU (1) HUE027232T2 (pl)
PL (1) PL2326307T3 (pl)
PT (1) PT2326307E (pl)
RU (1) RU2011108220A (pl)
WO (1) WO2010015298A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009056916B4 (de) 2009-12-03 2011-07-21 Siemens Medical Instruments Pte. Ltd. Hörgerät mit einer platzsparenden Anordnung von Mikrofonen und Schallöffnungen
DE102010003711B4 (de) * 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
DE102011051635B4 (de) 2011-07-07 2015-02-19 Borgwarner Ludwigsburg Gmbh Verfahren zum Steuern einer Korona Zündeinrichtung
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
DK3517541T3 (da) 2012-05-08 2020-09-07 Nicox Ophthalmics Inc Polymorf form af fluticasonpropionat
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
DE102012221219B4 (de) 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
HK1209638A1 (en) * 2012-12-14 2016-04-08 Glaxosmithkline Llc Pharmaceutical compositions
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
DE102013108705B4 (de) * 2013-08-12 2017-04-27 Borgwarner Ludwigsburg Gmbh Koronazündsystem und Verfahren zum Steuern einer Koronazündeinrichtung
JP2017528497A (ja) 2014-09-26 2017-09-28 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ 長時間作用型医薬組成物
CN108490793B (zh) * 2018-05-21 2021-07-27 山东大学 一种结晶过程粒度分布建模与控制方法
CN110655551A (zh) * 2019-09-23 2020-01-07 华润紫竹药业有限公司 一种地诺孕素药物单一新晶型及其制备方法
IT202100008834A1 (it) * 2021-04-08 2022-10-08 Ind Chimica Srl Processo per la preparazione di drospirenone come polvere fine tramite duplice cambio di forma cristallina
GB2620876B (en) * 2021-04-08 2025-04-09 Ind Chimica Srl Process for the preparation of drospirenone as a fine powder through a double change of crystalline form

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373315A1 (fr) 1976-12-09 1978-07-07 Kodak Pathe Procede de preparation de cristaux fins de substances minerales ou organiques
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
NL194638C (nl) 1986-12-19 2002-10-04 Novartis Ag Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
JP2642486B2 (ja) 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US5091187A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
EP0454138A2 (de) * 1990-04-26 1991-10-30 Vereinigte Aluminium-Werke Aktiengesellschaft Verbundpulver und Verfahren zum Beschichten von Keramikpulvern
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DK19393D0 (da) 1993-02-19 1993-02-19 Danochemo As Fremgangsmaade til fremstilling af et i vand dispergerbart pulverformigt carotenoidpraeparat
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5622938A (en) 1995-02-09 1997-04-22 Nano Systems L.L.C. Sugar base surfactant for nanocrystals
DE19652196A1 (de) 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
GB9919693D0 (en) * 1999-08-19 1999-10-20 Rhone Poulenc Rorer Ltd Process
BR0014159A (pt) 1999-08-31 2002-05-07 Schering Ag Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional
DE10043509A1 (de) 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
DE10214031A1 (de) 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
DE10218107A1 (de) 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
DE10325989A1 (de) 2003-06-07 2005-01-05 Glatt Gmbh Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
EP1625849A1 (en) 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
US7388096B2 (en) 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
DE102005053862A1 (de) 2005-11-04 2007-05-10 Pharmasol Gmbh Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel
EP1993513A4 (en) * 2006-03-14 2012-06-27 Merck Sharp & Dohme METHOD AND DEVICE FOR PREPARING CRYSTALLINE ORGANIC MICROPARTICLE COMPOSITIONS USING MICROMATES AND CRYSTALLIZING MICROSAMEN AND THEIR USE
EP1944018A1 (en) * 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Micronised particles of low-dosage strength active agents for powder formulations for inhalation

Also Published As

Publication number Publication date
RU2011108220A (ru) 2012-09-20
DE102008037025C5 (de) 2016-07-07
WO2010015298A3 (de) 2011-03-10
CH701977B1 (de) 2013-07-15
EP2944307A1 (de) 2015-11-18
WO2010015298A2 (de) 2010-02-11
EP2326307A2 (de) 2011-06-01
ES2557904T3 (es) 2016-01-29
CN102112113B (zh) 2014-06-25
AU2009278348A1 (en) 2010-02-11
CN102112113A (zh) 2011-06-29
CA2732952C (en) 2016-08-23
DK2326307T3 (en) 2016-01-25
PT2326307E (pt) 2016-02-02
CA2732952A1 (en) 2010-02-11
US9173843B2 (en) 2015-11-03
AU2009278348B2 (en) 2014-07-31
EP2326307B1 (de) 2015-10-28
DE102008037025B4 (de) 2011-09-22
HUE027232T2 (en) 2016-08-29
DE102008037025A1 (de) 2010-02-11
US20110144071A1 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
PL2326307T3 (pl) Sposób wytwarzania krystalicznych mikrocząstek substancji czynnej
EP2377858A4 (en) PROCESS FOR THE PRODUCTION OF GLYCOLIDE
PL2459176T3 (pl) Sposób krystalizacji i biodostępność
GB0819182D0 (en) Crystalline forms
PT2612859E (pt) Método para a produzir o derivado de 1-triazole-2-butanol
IL237642A (en) METHOD FOR PREPARING PHARMACEUTICAL MATERIALS
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
EP2246353A4 (en) PROCESS FOR PREPARING AN ADENINE COMPOUND
PT2639234T (pt) Derivativo cristalino de morfinan de 6,7-insaturado-7-carbamoil, e método para produzir o mesmo
PT2373616E (pt) Processo para a produção de isocianatos
PL2307356T3 (pl) Sposób wytwarzania izocyjanianów
ZA201100970B (en) Process for preparing microparticles
PL2349986T3 (pl) Sposób wytwarzania izocyjanianów
IL217656A (en) Method for producing 1,1,3-trichloro-1-propane
ZA201001209B (en) Method for producing ²-nitrostyrene compound
ZA201108342B (en) Method for producing microcapsule
IL210051A0 (en) Method for producing aminobiphenylene
PL2264023T3 (pl) Sposób wytwarzania związku pirymidynowego
PL2297041T3 (pl) Sposób wytwarzania mikrokrystalicznego tlenku tytanu
EP2248810A4 (en) METHOD FOR PRODUCING A PHENOXYPYRIDINE DERIVATIVE
IL210278A0 (en) Method for producing 3 - methyl - 2 - thiophenecarboxylic acid
IL210353A0 (en) Method for producing phenylalkane - 1 - ols
EP2374801A4 (en) PROCESS FOR THE PREPARATION OF A CHINAZOLINE DERIVATIVE
IL210119A (en) Process for the preparation of crystallidiphenic hydrochloride crystalline form v
IL211150A (en) METHOD FOR PRODUCING AN α-Hydroxyester Compound